240 related articles for article (PubMed ID: 11825009)
1. Invasive infections due to vancomycin-resistant enterococci in adult patients.
Jean SS; Fang CT; Wang HK; Hsue PR; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Dec; 34(4):281-6. PubMed ID: 11825009
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
3. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
Hagman HM; Strausbaugh LJ
Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections with vancomycin-resistant enterococci.
Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
[TBL] [Abstract][Full Text] [Related]
6. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
[TBL] [Abstract][Full Text] [Related]
7. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
[TBL] [Abstract][Full Text] [Related]
9. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
10. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
[TBL] [Abstract][Full Text] [Related]
11. [Vancomycin-resistant enterococci: ONERBA networks data and results of the national 2006 survey on digestive carriage].
Fortineau N; Leclercq R; Maugat S; Robert J;
Med Mal Infect; 2008 Jun; 38 Suppl 2():S65-7. PubMed ID: 18598874
[No Abstract] [Full Text] [Related]
12. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
Noskin GA; Cooper I; Peterson LR
Arch Intern Med; 1995 Jul; 155(13):1445-7. PubMed ID: 7794095
[TBL] [Abstract][Full Text] [Related]
13. Treatment of vancomycin-resistant Enterococcus faecium infections.
Lai KK
Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
[TBL] [Abstract][Full Text] [Related]
14. Emerging vancomycin resistance in enterococci in India.
Ghoshal U; Garg A; Tiwari DP; Ayyagari A
Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
19. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
20. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
